China Relies On Hospital Drug-Charge Change In Health-Reform Plan
This article was originally published in PharmAsia News
Executive Summary
One element of China's new health-care reform package involves a trial policy aimed at ending state-owned hospitals reliance on drug charges for income. Details of the plan have not been made public yet, but the intent is to reduce the tendency of physicians to prescribe expensive drugs rather than cheaper versions to drive up hospital income. Under the reform plan, those funds would be replaced in part by changes in medical insurance designed to reduce costs for the patients. (Click here for more
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.